Qube Research & Technologies LTD Cor Medix Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.22 - $4.61 $73,116 - $104,679	-22,707 Reduced 63.7%	12,938 $53,000
Q4 2022 Feb 14, 2023	BUY	$2.81 - $4.45 $24,404 - $38,648	8,685 Added 32.21%	35,645 $150,000
Q3 2022 Nov 14, 2022	SELL	$2.82 - $7.52 $12,238 - $32,636	-4,340 Reduced 13.87%	26,960 $76,000
Q2 2022 Aug 15, 2022	BUY	$2.73 - $5.61 $85,449 - $175,593	31,300 New	31,300 $126,000
Q3 2021 Nov 12, 2021	SELL	$4.46 - $7.11 $128,318 - $204,561	-28,771 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.05 - $10.09 $174,064 - $290,299	28,771 New	28,771 $197,000

114

17.7M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $405M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.